Literature DB >> 32618349

Tofacitinib in Hypertrophic Lichen Planus.

Peter Seiringer1, Felix Lauffer, Anna Caroline Pilz, Danielle Boehmer, Tilo Biedermann, Kilian Eyerich.   

Abstract

Entities:  

Keywords:  JAK inhibitors; tofacitinib; lichen planus

Mesh：

Substances：

Year:  2020        PMID： 32618349      PMCID： PMC9201967          DOI： 10.2340/00015555-3585

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  6 in total

1.  IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus.

Authors:  Shuai Shao; Lam C Tsoi; Mrinal K Sarkar; Xianying Xing; Ke Xue; Ranjitha Uppala; Celine C Berthier; Chang Zeng; Matthew Patrick; Allison C Billi; Joseph Fullmer; Maria A Beamer; Bethany Perez-White; Spiro Getsios; Andrew Schuler; John J Voorhees; Sung Choi; Paul Harms; J Michelle Kahlenberg; Johann E Gudjonsson
Journal:  Sci Transl Med       Date:  2019-09-25       Impact factor: 17.956

Review 2.  Clinical perspectives and murine models of lichenoid tissue reaction/interface dermatitis.

Authors:  Naoko Okiyama; Manabu Fujimoto
Journal:  J Dermatol Sci       Date:  2015-03-09       Impact factor: 4.563

3.  Treatment of severe lichen planus with the JAK inhibitor tofacitinib.

Authors:  William Damsky; Alice Wang; Brianna Olamiju; Danielle Peterson; Anjela Galan; Brett King
Journal:  J Allergy Clin Immunol       Date:  2020-02-01       Impact factor: 10.793

4.  Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis.

Authors:  Felix Lauffer; Manja Jargosch; Linda Krause; Natalie Garzorz-Stark; Regina Franz; Sophie Roenneberg; Alexander Böhner; Nikola S Mueller; Fabian J Theis; Carsten B Schmidt-Weber; Tilo Biedermann; Stefanie Eyerich; Kilian Eyerich
Journal:  J Invest Dermatol       Date:  2018-03-09       Impact factor: 8.551

5.  JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases.

Authors:  Ana Karina Alves de Medeiros; Reinhart Speeckaert; Eline Desmet; Mireille Van Gele; Sofie De Schepper; Jo Lambert
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

Review 6.  Immune response patterns in non-communicable inflammatory skin diseases.

Authors:  K Eyerich; S Eyerich
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-01-15       Impact factor: 6.166
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.